Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual.

Galante PA, Parmigiani RB, Zhao Q, Caballero OL, de Souza JE, Navarro FC, Gerber AL, Nicolás MF, Salim AC, Silva AP, Edsall L, Devalle S, Almeida LG, Ye Z, Kuan S, Pinheiro DG, Tojal I, Pedigoni RG, de Sousa RG, Oliveira TY, de Paula MG, Ohno-Machado L, Kirkness EF, Levy S, da Silva WA Jr, Vasconcelos AT, Ren B, Zago MA, Strausberg RL, Simpson AJ, de Souza SJ, Camargo AA.

Nucleic Acids Res. 2011 Aug;39(14):6056-68. doi: 10.1093/nar/gkr221. Epub 2011 Apr 14.

2.

Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines.

Hampton OA, Koriabine M, Miller CA, Coarfa C, Li J, Den Hollander P, Schoenherr C, Carbone L, Nefedov M, Ten Hallers BF, Lee AV, De Jong PJ, Milosavljevic A.

Cancer Genet. 2011 Aug;204(8):447-57. doi: 10.1016/j.cancergen.2011.07.009. Erratum in: Cancer Genet. 2011 Dec;204(12):694. Coarfa, Cristian [added];Schoenherr, Caroline [added].

3.

Genome-wide functional synergy between amplified and mutated genes in human breast cancer.

Nikolsky Y, Sviridov E, Yao J, Dosymbekov D, Ustyansky V, Kaznacheev V, Dezso Z, Mulvey L, Macconaill LE, Winckler W, Serebryiskaya T, Nikolskaya T, Polyak K.

Cancer Res. 2008 Nov 15;68(22):9532-40. doi: 10.1158/0008-5472.CAN-08-3082.

4.

Chromosomal mutagen sensitivity associated with mutations in BRCA genes.

Speit G, Trenz K.

Cytogenet Genome Res. 2004;104(1-4):325-32. Review.

PMID:
15162060
5.

Comprehensive characterization of the genomic alterations in human gastric cancer.

Cui J, Yin Y, Ma Q, Wang G, Olman V, Zhang Y, Chou WC, Hong CS, Zhang C, Cao S, Mao X, Li Y, Qin S, Zhao S, Jiang J, Hastings P, Li F, Xu Y.

Int J Cancer. 2015 Jul 1;137(1):86-95. doi: 10.1002/ijc.29352. Epub 2014 Dec 3.

6.

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.

Gast A, Scherer D, Chen B, Bloethner S, Melchert S, Sucker A, Hemminki K, Schadendorf D, Kumar R.

Genes Chromosomes Cancer. 2010 Aug;49(8):733-45. doi: 10.1002/gcc.20785.

PMID:
20544847
7.

DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes.

Woo YH, Li WH.

Nat Commun. 2012;3:1004. doi: 10.1038/ncomms1982.

PMID:
22893128
8.

Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors.

Zientek-Targosz H, Kunnev D, Hawthorn L, Venkov M, Matsui S, Cheney RT, Ionov Y.

Mol Cancer. 2008 Jun 5;7:51. doi: 10.1186/1476-4598-7-51.

9.

Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.

Zhao Q, Kirkness EF, Caballero OL, Galante PA, Parmigiani RB, Edsall L, Kuan S, Ye Z, Levy S, Vasconcelos AT, Ren B, de Souza SJ, Camargo AA, Simpson AJ, Strausberg RL.

Genome Biol. 2010;11(11):R114. doi: 10.1186/gb-2010-11-11-r114. Epub 2010 Nov 25.

10.

Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis.

Babenko VN, Basu MK, Kondrashov FA, Rogozin IB, Koonin EV.

BMC Cancer. 2006 Feb 9;6:36.

11.

[Correlation of breast tumor pathogenesis and somatic mutations on the basis of mitochondrial DNA whole genome].

Yang Y, He JD, Guo XJ, Che YH, Zhang Y, Li L.

Zhonghua Yi Xue Za Zhi. 2011 Apr 12;91(14):973-6. Chinese.

PMID:
21609549
12.

The relative timing of mutations in a breast cancer genome.

Newman S, Howarth KD, Greenman CD, Bignell GR, Tavaré S, Edwards PA.

PLoS One. 2013 Jun 10;8(6):e64991. doi: 10.1371/journal.pone.0064991. Print 2013.

13.

The somatic autosomal mutation matrix in cancer genomes.

Temiz NA, Donohue DE, Bacolla A, Vasquez KM, Cooper DN, Mudunuri U, Ivanic J, Cer RZ, Yi M, Stephens RM, Collins JR, Luke BT.

Hum Genet. 2015 Aug;134(8):851-64. doi: 10.1007/s00439-015-1566-1. Epub 2015 May 23. Erratum in: Hum Genet. 2015 Aug;134(8):865-7.

14.

Somatic alterations in the human cancer genome.

Weir B, Zhao X, Meyerson M.

Cancer Cell. 2004 Nov;6(5):433-8. Review.

15.

Diverse mechanisms of somatic structural variations in human cancer genomes.

Yang L, Luquette LJ, Gehlenborg N, Xi R, Haseley PS, Hsieh CH, Zhang C, Ren X, Protopopov A, Chin L, Kucherlapati R, Lee C, Park PJ.

Cell. 2013 May 9;153(4):919-29. doi: 10.1016/j.cell.2013.04.010. Erratum in: Cell. 2014 Jun 19;157(7):1736.

16.

Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.

Mithani SK, Smith IM, Topalian SL, Califano JA.

Melanoma Res. 2008 Jun;18(3):214-9. doi: 10.1097/CMR.0b013e3282f88a56.

PMID:
18477896
17.

Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.

Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW, Lin CH, Chen YJ, Gu DL, Lin CH, Wu JY, Chen YT, Hsu MT, Jou YS.

Hepatology. 2010 Nov;52(5):1690-701. doi: 10.1002/hep.23847.

PMID:
20799341
18.

Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.

Villaronga MA, López-Mateo I, Markert L, Espinosa E, Fresno Vara JA, Belandia B.

Breast Cancer Res Treat. 2011 Aug;128(3):891-8. doi: 10.1007/s10549-011-1492-4. Epub 2011 Apr 5.

PMID:
21465167
19.

Decoding the fine-scale structure of a breast cancer genome and transcriptome.

Volik S, Raphael BJ, Huang G, Stratton MR, Bignel G, Murnane J, Brebner JH, Bajsarowicz K, Paris PL, Tao Q, Kowbel D, Lapuk A, Shagin DA, Shagina IA, Gray JW, Cheng JF, de Jong PJ, Pevzner P, Collins C.

Genome Res. 2006 Mar;16(3):394-404. Epub 2006 Feb 3.

20.

Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.

Isfort RJ, Cody DB, Lovell GJ, Gioeli D, Weissman BE, Doersen CJ.

Mol Carcinog. 1999 May;25(1):30-41.

PMID:
10331742

Supplemental Content

Support Center